carteolol has been researched along with Cardiomyopathy, Congestive in 4 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carteolol treatment increased beta-adrenergic receptor density, and the high carteolol dose restored SR Ca2+-ATPase and myofibrillar ATPase activities, along with creatine kinase, lactate dehydrogenase, aspartate transaminase, and ATP synthase activities, to normal." | 5.30 | Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. ( Bristow, MR; DiSalvo, TG; Gwathmey, JK; Hajjar, RJ; Khan, F; Kim, CS; Matsumori, A, 1999) |
| "Carteolol treatment increased beta-adrenergic receptor density, and the high carteolol dose restored SR Ca2+-ATPase and myofibrillar ATPase activities, along with creatine kinase, lactate dehydrogenase, aspartate transaminase, and ATP synthase activities, to normal." | 1.30 | Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. ( Bristow, MR; DiSalvo, TG; Gwathmey, JK; Hajjar, RJ; Khan, F; Kim, CS; Matsumori, A, 1999) |
| "Metoprolol did not cause any significant changes compared with the control group." | 1.28 | Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taniguchi, Y | 1 |
| Ueshima, K | 1 |
| Chiba, I | 1 |
| Segawa, I | 1 |
| Kobayashi, N | 1 |
| Saito, M | 1 |
| Hiramori, K | 1 |
| Gwathmey, JK | 2 |
| Kim, CS | 1 |
| Hajjar, RJ | 2 |
| Khan, F | 1 |
| DiSalvo, TG | 1 |
| Matsumori, A | 2 |
| Bristow, MR | 1 |
| Washington, B | 1 |
| Butler, K | 1 |
| Doye, AA | 1 |
| Jang, M | 1 |
| Tominaga, M | 1 |
| Okada, I | 1 |
| Yamada, T | 1 |
| Kawai, C | 1 |
4 other studies available for carteolol and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
A new method using pulmonary gas-exchange kinetics to evaluate efficacy of beta-blocking agents in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Cardiomyopathy, Dilated; Carteol | 2003 |
Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol.
Topics: Adenosine Triphosphate; Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Blood Pressure; Bod | 1999 |
Heart function challenged with beta-receptor agonism or antagonism in a heart failure model.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Blood Pressure; Ca | 2001 |
Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Cardiomyopathy, Dilated; Carteolol; Drug Evaluati | 1991 |